Skip to content

Insider · CIK 0001843872

Kevin Richard Haas

officer

Files at MYGN (MYRIAD GENETICS INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 22, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-1,694$10.01$17k186,029Mar 25, 2025
Mar 22, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-4,493$10.01$45k181,536Mar 25, 2025
Mar 24, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-1,177$9.98$12k180,359Mar 25, 2025
Mar 24, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-1,724$9.98$17k178,635Mar 25, 2025
Mar 13, 2025MYGN
MYRIAD GENETICS INC
AGrant or award
Common Stock
+54,124$0.00$0195,448Mar 17, 2025
Mar 14, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-4,390$10.07$44k191,058Mar 17, 2025
Mar 15, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-3,335$10.07$34k187,723Mar 17, 2025
Feb 7, 2025MYGN
MYRIAD GENETICS INC
AGrant or award
Common Stock
+12,758$0.00$0141,324Mar 4, 2025
Feb 25, 2025MYGN
MYRIAD GENETICS INC
FTax withholding
Common Stock
-1,016$11.74$12k128,566Feb 26, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin Richard Haas: insider trades and track record | InsiderTell